Technical Analysis for NOVN - Novan, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Historical NOVN trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Fell Below 20 DMA | Bearish | -1.79% | |
| Wide Bands | Range Expansion | -1.79% | |
| Bearish Engulfing | Bearish | -13.89% | |
| 1,2,3 Retracement Bearish | Bearish Swing Setup | -13.89% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -13.89% | |
| 20 DMA Support | Bullish | -13.89% | |
| Outside Day | Range Expansion | -13.89% |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/01/2020
- Sector: Healthcare
- Industry: Biotechnology
Novan, Inc. is a late-stage pharmaceutical company. The Company is engaged in the development and commercialization of therapies using its nitric oxide platform. The Company develops product candidates using its Nitricil technology, which enables the Company to engineer tunable new chemical entities (NCEs). The Company's formulation science enables it to further tune the release of nitric oxide when applied to the skin by using the combinations of inactive ingredients. It is developing SB204 for the treatment of acne vulgaris in Phase III. The Company is developing its product candidate, SB206, for the treatment of external genital and perianal warts in Phase II. It is developing SB208, an investigational topical anti-fungal for the treatment of fungal infections of the skin and nails. It is developing SB204 for the treatment of inflammatory skin diseases. Its pipeline also includes SB414, a topical cream product candidate.
Medical Specialties Organ Systems Infectious Diseases Acne Product Candidates Acne Vulgaris Cutaneous Conditions Fungal Infections Inflammatory Skin Diseases Treatment Of Inflammatory Skin Diseases Wart
Medical Specialties Organ Systems Infectious Diseases Acne Product Candidates Acne Vulgaris Cutaneous Conditions Fungal Infections Inflammatory Skin Diseases Treatment Of Inflammatory Skin Diseases Wart
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.72 |
| 52 Week Low | 0.41 |
| Average Volume | 672,618 |
| 200-Day Moving Average | 2.11 |
| 50-Day Moving Average | 1.17 |
| 20-Day Moving Average | 0.50 |
| 10-Day Moving Average | 0.48 |
| Average True Range | 0.07 |
| ADX | 37.61 |
| +DI | 17.11 |
| -DI | 35.79 |
| Chandelier Exit (Long, 3 ATRs ) | 0.45 |
| Chandelier Exit (Short, 3 ATRs ) | 0.63 |
| Upper Bollinger Band | 0.59 |
| Lower Bollinger Band | 0.40 |
| Percent B (%b) | 0.24 |
| BandWidth | 37.38 |
| MACD Line | -0.15 |
| MACD Signal Line | -0.20 |
| MACD Histogram | 0.0478 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.48 | ||||
| Resistance 3 (R3) | 0.49 | 0.48 | 0.48 | ||
| Resistance 2 (R2) | 0.48 | 0.47 | 0.48 | 0.47 | |
| Resistance 1 (R1) | 0.46 | 0.47 | 0.46 | 0.46 | 0.47 |
| Pivot Point | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 |
| Support 1 (S1) | 0.44 | 0.45 | 0.44 | 0.44 | 0.43 |
| Support 2 (S2) | 0.44 | 0.44 | 0.43 | 0.43 | |
| Support 3 (S3) | 0.42 | 0.44 | 0.42 | ||
| Support 4 (S4) | 0.42 |
